Keck School of Medicine researchers receive $12 million grant to study early liver transplantation

Alcohol-associated liver disease accounts for 50% of liver-related deaths, and its rates are rising worldwide.

Is obesity an independent risk factor for cardiovascular disease?

Researchers explore how obesity contributes to cardiovascular disease by investigating this association in low-risk people.

November 10, 2023

GLP-1 Agonists May Offer Protection Against Glaucoma in Type 2 Diabetes

Diabetic patients treated with GLP-1 receptor agonists (GLP-1RAs) had a significantly lower risk of developing glaucoma as compared with metformin, a large retrospective cohort study

August 29, 2024

Merck and Eisai to stop Keytruda plus Lenvima trial in head and neck cancer after disappointing interim results

Merck and Eisai announced Friday morning that they plan to close a Phase III study of the combination of Keytruda and Eisai’s tyrosine kinase inhibitor

August 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.